W Polsce: Wkrótce rekrutacjaNa świecie: RekrutujeFaza III
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Miasta: Katowice, Kraków, Lublin, Mysłowice i 4 inne miastaWiek: od 18 latSponsor: Glaxosmithkline Research & Development Limited
RekrutujeFaza III
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Miasta: Katowice, Kraków, Lublin, Mysłowice i 4 inne miastaWiek: od 18 latSponsor: Glaxosmithkline Research & Development Limited
RekrutujeFaza III
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Miasta: Białystok, Gdańsk, Katowice, Mysłowice i 5 innych miastWiek: od 18 latSponsor: Eli Lilly & Co.
RekrutujeFaza III
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Miasta: Kraków, Lublin, Mysłowice, Warszawa i 2 inne miastaWiek: od 18 latSponsor: Boehringer Ingelheim International GmbH
RekrutujeFaza III
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Miasta: Kraków, Lublin, Mysłowice, Warszawa i 2 inne miastaWiek: od 18 latSponsor: Boehringer Ingelheim International GmbH
RekrutujeFaza II
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Miasta: Katowice, Mysłowice, Szczecin, WarszawaWiek: od 18 latSponsor: Glaxosmithkline Research & Development Limited
RekrutujeFaza III
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Miasta: Katowice, Kraków, Mysłowice, Warszawa i 2 inne miastaWiek: od 18 latSponsor: F. Hoffmann-La Roche AG
RekrutujeFaza III
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Miasta: Katowice, Kraków, Mysłowice, Warszawa i 2 inne miastaWiek: od 18 latSponsor: F. Hoffmann-La Roche AG
W Polsce: ZakończoneNa świecie: RekrutujeFaza III
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
Miasta: MysłowiceWiek: od 18 latSponsor: Takeda Development Center Americas Inc.
RekrutujeFaza III
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
Miasta: Mysłowice, Warszawa, ŚląskieWiek: od 18 latSponsor: Takeda Development Center Americas Inc.
Rekrutacja wkrótceFaza II
A Dose-finding, Double-blind, Randomized, Placebo-controlled Phase 2 Study to Evaluate the Efficacy and Safety of Treatment with Efimosfermin Alfa in Adult Participants with…
Miasta: Katowice, Kraków, MysłowiceWiek: od 18 latSponsor: Glaxosmithkline Research & Development Limited